
doi: 10.4267/2042/69021
handle: 2042/69021
Mantle cell lymphoma (MCL) is a B-cell neoplasm that usually carries the t(11;14)(q13;q32) translocation and constitutively overexpresses cyclin D1. The clinical evolution is relatively aggressive with a poor response to conventional therapeutic regimens, frequent relapses and a median overall survival of 3-5 years. MCL has a wide spectrum of growth patterns. Most cases have a vaguely nodular and/or diffuse growth pattern, very rare cases have a follicular growth pattern, and a larger minority
Mantle cell lymphoma, Leukaemia Section, in situ mantle cell lymphoma
Mantle cell lymphoma, Leukaemia Section, in situ mantle cell lymphoma
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
